Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly #InPursuitOfAnswers.
Burlington, N.C., USA
- Tweets 3,821
- Following 221
- Followers 8,696
- Likes 480
Hi there, we’re sorry to hear about the repeated difficulties you’ve experienced during your visits this week. We’d like to better understand what happened. Please send us a DM with the location you’re visiting, along with your full name and best contact information. nitter.net/messages/compose?recip…
6
Hi Pete, thanks for reaching out. We're sorry you haven't received your results yet. Please DM us with your full name, date of birth, and best contact information, so that we can escalate this to the appropriate team to help resolve. nitter.net/messages/compose?recip…
8
Labcorp will offer the FDA-cleared Elecsys® pTau217 test, supporting a more consistent approach to assessing amyloid pathology associated with Alzheimer’s disease across care settings.
Learn more: bit.ly/4cXZiOZ
#AlzheimersDisease #Neurology #Diagnostics
4
2
5
709
Today, we're introducing the Marker by Labcorp™ Genetic Health Panel, a new offering designed to help people better understand inherited risks associated with more than 100 medically actionable health conditions.
Learn more: bit.ly/3Tkngx7
5
2
5
1,038
From our team to yours, happy holidays and happy new year. Thank you for helping us improve health and improve lives worldwide.
#HappyHolidays #NewYear
22
9
2,995
We’re thrilled to be recognized as one of Forbes’ America’s Dream Employers for 2026!
This recognition reflects our commitment to creating an environment where people feel inspired, supported, and empowered to do their best work.
lnkd.in/eWBy-hpD
10
2
8
2,417
Hi there, Thank you for your message. We take these issues very seriously. We will share this information with our Courier team to file an incident report.
1
20
Thank you for bringing this to our attention. We are actively investigating reports related to employee conduct and take all concerns seriously.
55
20
409
4,278
The first FDA-cleared blood test for the evaluation of Alzheimer’s is here. Labcorp is proud to offer Lumipulse® pTau-217/Beta Amyloid 42 Ratio, reflecting our commitment to Alzheimer's care.
Learn more: spr.ly/6011fQ01X
181
6
17
5,392
How are blood tests changing cancer monitoring and Alzheimer’s detection?
On the Becker’s Healthcare Podcast, Labcorp’s Dr. Mindy Nye breaks down what’s next in diagnostics.
spr.ly/60154qnXJ
36
2
13
6,114
Taking on a new role without all the answers? That’s normal, and it’s how growth begins. In this episode of the Future of HR Podcast, Labcorp’s CHRO Anita Graham shares her perspective on building a career with intention, cultivating curiosity and learning by doing.
9
5
2,185
This Father’s Day, encourage your loved ones to make their health a priority. Preventive checkups can help identify issues early and support long-term wellness.
Check out our preventive health checklist: spr.ly/60104MRIo
#MensHealthMonth #FathersDay
11
1
7
1,790
The FDA has cleared the first blood-based biomarker test for Alzheimer’s: Fujirebio’s pTau-217/Beta Amyloid 42 Ratio test.
Learn more about this major step toward earlier, more precise and less invasive care:
spr.ly/6014NqQ1O
2
2
5
1,187
Today and every day, we recognize the dedication, expertise and hard work of our lab professionals. Your efforts help deliver timely results, support innovation and play a key role in improving patient care.
We’re grateful for the impact you make. Thank you.
#LabWeek
4
1
5
1,308
As we celebrate #EarthDay, we're committed to making a positive impact on the planet.
Which of these environmental and sustainability goals do you think we’re focusing on this year?
Read more in our latest #CorporateResponsibilityReport: spr.ly/60142nKv6
0%
Use more renewable power
0%
Enhance fleet efficiency
50%
Improve waste management
50%
All of the above
4 votes • Final results
2
3
1,002